{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 77,
        "end": 79
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 124,
        "end": 128
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 214,
        "end": 228
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 92,
        "end": 109
      }
    },
    {
      "id": "T10",
      "obj": "Disease",
      "span": {
        "begin": 124,
        "end": 149
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25871911_11",
  "text": "These surprising findings in a group of phenotypically similar patients with ER -positive , endocrine therapy -pretreated , HER2 -negative metastases , are supported by preclinical data showing that sensitivity to 5-fluorouracil is enhanced by deficiencies in chromatin remodeling and homologous recombination genes ."
}
